STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF RELATED SUBSTANCES FOR DOLUTEGRAVIR DISPERSIBLE TABLETS.

MLA

Velusamy, Manikandan, et al. “Stability Indicating Rp-Hplc Method Development and Validation of Related Substances for Dolutegravir Dispersible Tablets.” Pharmacophore, vol. 13, no. 2, Mar. 2022, pp. 56–64. EBSCOhost, https://doi.org/10.51847/2MarzXSiL2.

APA

Velusamy, M., Nagarajan, S., Rathinam, V., & Murali. (2022). Stability Indicating Rp-Hplc Method Development and Validation of Related Substances for Dolutegravir Dispersible Tablets. Pharmacophore, 13(2), 56–64. https://doi.org/10.51847/2MarzXSiL2

Chicago

Velusamy, Manikandan, Srinivasan Nagarajan, Vinoth Rathinam, and Murali. 2022. “Stability Indicating Rp-Hplc Method Development and Validation of Related Substances for Dolutegravir Dispersible Tablets.” Pharmacophore 13 (2): 56–64. doi:10.51847/2MarzXSiL2.